Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Inherited prethrombotic disorders and infectious purpura.

Westendorp RG, Reitsma PH, Bertina RM.

Thromb Haemost. 1996 Jun;75(6):899-901.

PMID:
8822583
2.

Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families.

Martinelli I, Mannucci PM, De Stefano V, Taioli E, Rossi V, Crosti F, Paciaroni K, Leone G, Faioni EM.

Blood. 1998 Oct 1;92(7):2353-8.

3.

Activated protein C resistance--a major risk factor for thrombosis.

Rosén SB, Sturk A.

Eur J Clin Chem Clin Biochem. 1997 Jul;35(7):501-16. Review.

PMID:
9263726
4.

Retinal vascular occlusion and deficiencies in the protein C pathway.

Greiner K, Hafner G, Dick B, Peetz D, Prellwitz W, Pfeiffer N.

Am J Ophthalmol. 1999 Jul;128(1):69-74.

PMID:
10482096
5.

Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.

El-Karaksy H, El-Koofy N, El-Hawary M, Mostafa A, Aziz M, El-Shabrawi M, Mohsen NA, Kotb M, El-Raziky M, El-Sonoon MA, A-Kader H.

Ann Hematol. 2004 Nov;83(11):712-5. Epub 2004 Aug 10. Erratum in: Ann Hematol. 2005 Mar;84(3):205.

PMID:
15309526
7.

The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis.

Egesel T, Büyükasik Y, Dündar SV, Gürgey A, Kirazli S, Bayraktar Y.

J Clin Gastroenterol. 2000 Jan;30(1):66-71.

PMID:
10636214
9.

Activated-protein-C resistance in cancer patients.

Green D, Maliekel K, Sushko E, Akhtar R, Soff GA.

Haemostasis. 1997 May-Jun;27(3):112-8.

PMID:
9306127
10.

Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.

Price DT, Ridker PM.

Ann Intern Med. 1997 Nov 15;127(10):895-903. Review.

PMID:
9382368
11.

Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?

Linnemann B, Schindewolf M, Zgouras D, Erbe M, Jarosch-Preusche M, Lindhoff-Last E.

Thromb Res. 2008;121(6):743-50. Epub 2007 Sep 4.

PMID:
17804043
12.

Effect of the Factor V Leiden mutation on the severity of meningococcal disease.

Kondaveeti S, Hibberd ML, Booy R, Nadel S, Levin M.

Pediatr Infect Dis J. 1999 Oct;18(10):893-6.

PMID:
10530586
13.

Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.

Dahlbäck B, Zöller B, Hillarp A.

Haemostasis. 1996 Oct;26 Suppl 4:301-14. Review.

PMID:
8979136
14.

Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.

Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, van Hattum J, Chamuleau RA, Adang RP, Vandenbroucke JP, van Hoek B, Rosendaal FR.

Blood. 2000 Oct 1;96(7):2364-8.

15.

Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy.

Hallak M, Senderowicz J, Cassel A, Shapira C, Aghai E, Auslender R, Abramovici H.

Am J Obstet Gynecol. 1997 Apr;176(4):889-93.

PMID:
9125617
17.

Inherited thrombotic disorders: an update.

Florell SR, Rodgers GM.

Am J Hematol. 1997 Jan;54(1):53-60. Review.

18.
19.

Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients.

Gaustadnes M, Rüdiger N, Møller J, Rasmussen K, Bjerregaard Larsen T, Ingerslev J.

Blood Coagul Fibrinolysis. 1999 Jul;10(5):251-9.

PMID:
10456616
20.

Supplemental Content

Support Center